HEPACAM2
HEPACAM2 (HEPACAM family member 2, also known as FLJ38683) is an immunoglobulin superfamily-related protein required for mitosis. It moves from the Golgi apparatus to mitotic centrosomes and supports centrosome maturation during prometaphase. Browse Assay Genie's current range of HEPACAM2 research reagents below, or read on for the biology behind the target.
HEPACAM2 is required during prometaphase for centrosome maturation. Following poly-ADP-ribosylation (PARsylation) by TNKS, the protein translocates from the Golgi apparatus to mitotic centrosomes. There it plays a key role in forming robust microtubules, which allow prompt movement of chromosomes. It does this by anchoring AKAP9/CG-NAP, a scaffold protein of the gamma-tubulin ring complex, and so promotes centrosome maturation.
The HEPACAM2 gene encodes a protein related to the immunoglobulin superfamily, and HGNC places it in the V-set domain containing and I-set domain containing gene groups. UniProt records its subcellular locations as the Golgi apparatus membrane, the spindle, the centrosome and the midbody, which fits a role that follows the cell through mitosis. A mouse ortholog, Hepacam2, is recognised.
Functional studies summarised by RefSeq show that knockdown of the gene results in prometaphase arrest, abnormal nuclear morphology and apoptosis. A chromosomal deletion that includes the gene may be associated with myeloid leukaemia and myelodysplastic syndrome in human patients. These findings make the HEPACAM2 protein a useful subject for work on mitotic progression and centrosome biology.
HEPACAM2 is needed for progression through prometaphase, and its knockdown causes arrest, abnormal nuclear morphology and apoptosis.
The protein anchors AKAP9/CG-NAP, a scaffold of the gamma-tubulin ring complex, to promote centrosome maturation.
HEPACAM2 contributes to robust microtubule formation, allowing prompt movement of chromosomes during mitosis.
A chromosomal deletion including the HEPACAM2 gene may be associated with myeloid leukaemia and myelodysplastic syndrome.
HEPACAM2 is required during prometaphase for centrosome maturation. After PARsylation by TNKS, it moves from the Golgi apparatus to mitotic centrosomes, where it anchors AKAP9/CG-NAP and promotes formation of robust microtubules for prompt chromosome movement.
The official name is HEPACAM family member 2, and FLJ38683 is a recorded alias. HGNC classes the gene in the V-set domain containing and I-set domain containing groups, and NCBI describes the protein as related to the immunoglobulin superfamily.
RefSeq reports that a chromosomal deletion including the HEPACAM2 gene may be associated with myeloid leukaemia and myelodysplastic syndrome in human patients. Knockdown causes prometaphase arrest and apoptosis. A mouse ortholog, Hepacam2, exists; check the datasheet of any product for its validated reactivity.
Centrosome scaffold proteins, PARsylation enzymes and related HEPACAM family members relevant to mitosis research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt A8MVW5; product specifications from Assay Genie datasheets.